FOURTH AMENDMENT TO CONSOLIDATED EXCLUSIVE AGENCY AND DISTRIBUTION AGREEMENTAgency and Distribution Agreement • April 27th, 2020
Contract Type FiledApril 27th, 2020This Fourth Amendment to the Consolidated Exclusive Agency and Distribution Agreement (“Fourth Amendment”) is made effective as of May 1st, 2020 ("Fourth Amendment Effective Date") by and between Dr. Falk Pharma GmbH, a limited liability company incorporated in Germany having its registered office and principal place of business at Leinenweberstraße 5, 79108 Freiburg, Germany ("Falk") and CMS Bridging Limited, a company incorporated under the laws of Hong Kong registered with the Commercial Register of 65662916 and with its registered office at Unit 2106, 21/F, Island Place Tower, 510 King’s Road, North Point, Hong Kong ("CMS").